Dr Nicole A Nagel, MD - Medicare Family Practice in Lafayette, CO

Dr Nicole A Nagel, MD is a medicare enrolled "Family Medicine" physician in Lafayette, Colorado. She went to University Of Colorado School Of Medicine, Denver and graduated in 2003 and has 21 years of diverse experience with area of expertise as Family Practice. She is a member of the group practice Colorado Permanente Medical Group Pc and her current practice location is 280 Exempla Cir, Lafayette, Colorado. You can reach out to her office (for appointments etc.) via phone at (303) 338-4545.

Dr Nicole A Nagel is licensed to practice in Colorado (license number 42882) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1316077159.

Contact Information

Dr Nicole A Nagel, MD
280 Exempla Cir,
Lafayette, CO 80026-3370
(303) 338-4545
Not Available



Physician's Profile

Full NameDr Nicole A Nagel
GenderFemale
SpecialityFamily Practice
Experience21 Years
Location280 Exempla Cir, Lafayette, Colorado
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Nicole A Nagel attended and graduated from University Of Colorado School Of Medicine, Denver in 2003
  NPI Data:
  • NPI Number: 1316077159
  • Provider Enumeration Date: 03/07/2007
  • Last Update Date: 05/15/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 4385732072
  • Enrollment ID: I20071113000702

Medical Identifiers

Medical identifiers for Dr Nicole A Nagel such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1316077159NPI-NPPES
21801789MedicaidCO
017527OtherKAISER-COMMERCIAL NUMBER

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 42882 (Colorado)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Colorado Permanente Medical Group Pc12542384541113

News Archive

Exposure to uranium may increase lupus rates

People living near a former uranium ore processing facility in Ohio are experiencing a higher than average rate of lupus, according a new study conducted by scientists at the University of Cincinnati and Cincinnati Children's Hospital Medical Center.

High-throughput RNA interference screen identifies potential drug target against henipaviruses

The closely related Hendra and Nipah viruses (referred to jointly as henipaviruses) are deadly cousins of the more common mumps, measles, and respiratory syncytial viruses, all members of the paramyxovirus family. Henipavirus outbreaks are on the rise, but little is known about them, partly because research has to be conducted under extreme level containment conditions.

Study may lend insight about hallucination mechanism in schizophrenia

Scripps Research Institute scientists have shown for the first time that the neurotransmitter serotonin uses a specialized signaling pathway to mediate biological functions that are distinct from the signaling pathways used by hallucinogenic substances. The new findings could have a profound effect on the development of new therapies for a number of disorders, including schizophrenia and depression.

GICD, Stanford University collaborate to develop stem cell and regenerative medicine therapies

Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.

A.P. Pharma submits NDA for APF530 in chemo-induced nausea and vomiting

A.P. Pharma, Inc. has announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and Drug Administration (FDA). APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron that utilizes the Company's proprietary Biochronomer drug delivery system.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Nicole A Nagel allows following entities to bill medicare on her behalf.
Entity NameColorado Permanente Medical Group Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760599724
PECOS PAC ID: 1254238454
Enrollment ID: O20031216000640

News Archive

Exposure to uranium may increase lupus rates

People living near a former uranium ore processing facility in Ohio are experiencing a higher than average rate of lupus, according a new study conducted by scientists at the University of Cincinnati and Cincinnati Children's Hospital Medical Center.

High-throughput RNA interference screen identifies potential drug target against henipaviruses

The closely related Hendra and Nipah viruses (referred to jointly as henipaviruses) are deadly cousins of the more common mumps, measles, and respiratory syncytial viruses, all members of the paramyxovirus family. Henipavirus outbreaks are on the rise, but little is known about them, partly because research has to be conducted under extreme level containment conditions.

Study may lend insight about hallucination mechanism in schizophrenia

Scripps Research Institute scientists have shown for the first time that the neurotransmitter serotonin uses a specialized signaling pathway to mediate biological functions that are distinct from the signaling pathways used by hallucinogenic substances. The new findings could have a profound effect on the development of new therapies for a number of disorders, including schizophrenia and depression.

GICD, Stanford University collaborate to develop stem cell and regenerative medicine therapies

Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.

A.P. Pharma submits NDA for APF530 in chemo-induced nausea and vomiting

A.P. Pharma, Inc. has announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and Drug Administration (FDA). APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron that utilizes the Company's proprietary Biochronomer drug delivery system.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Nicole A Nagel is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Nicole A Nagel, MD
10350 E Dakota Ave,
Denver, CO 80247-1314

Ph: () -
Dr Nicole A Nagel, MD
280 Exempla Cir,
Lafayette, CO 80026-3370

Ph: (303) 338-4545

News Archive

Exposure to uranium may increase lupus rates

People living near a former uranium ore processing facility in Ohio are experiencing a higher than average rate of lupus, according a new study conducted by scientists at the University of Cincinnati and Cincinnati Children's Hospital Medical Center.

High-throughput RNA interference screen identifies potential drug target against henipaviruses

The closely related Hendra and Nipah viruses (referred to jointly as henipaviruses) are deadly cousins of the more common mumps, measles, and respiratory syncytial viruses, all members of the paramyxovirus family. Henipavirus outbreaks are on the rise, but little is known about them, partly because research has to be conducted under extreme level containment conditions.

Study may lend insight about hallucination mechanism in schizophrenia

Scripps Research Institute scientists have shown for the first time that the neurotransmitter serotonin uses a specialized signaling pathway to mediate biological functions that are distinct from the signaling pathways used by hallucinogenic substances. The new findings could have a profound effect on the development of new therapies for a number of disorders, including schizophrenia and depression.

GICD, Stanford University collaborate to develop stem cell and regenerative medicine therapies

Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.

A.P. Pharma submits NDA for APF530 in chemo-induced nausea and vomiting

A.P. Pharma, Inc. has announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and Drug Administration (FDA). APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron that utilizes the Company's proprietary Biochronomer drug delivery system.

Read more News

› Verified 6 days ago


Family Medicine Doctors in Lafayette, CO

Dr. Herman Andrew Damek, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 W South Boulder Rd, Suite 110, Lafayette, CO 80026
Phone: 303-415-4355    Fax: 303-666-1982
Dr. Sean M. Haney, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 280 Exempla Cir, Lafayette, CO 80026
Phone: 303-338-4545    
Dr. Paul Kenneth Branch, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 380 Empire Rd, #120, Lafayette, CO 80026
Phone: 866-477-1169    Fax: 800-593-2559
Susan Bernice Dowdy, M.D.
Family Medicine
Medicare: May Accept Medicare Assignments
Practice Location: 2600 Campus Dr, Suite A, Lafayette, CO 80026
Phone: 303-673-1900    Fax: 303-673-1933
Stephen L Zakany, M.D.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1000 W S Boulder Rd, Ste 110, Lafayette, CO 80026
Phone: 303-666-7555    Fax: 303-666-9168
Paul Edward Mackell, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 588 Us Highway 287, Suite 204, Lafayette, CO 80026
Phone: 303-666-4606    Fax: 303-666-4610
Dr. Christy Tran Kleinke, DO
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 W South Boulder Rd, Suite 110, Lafayette, CO 80026
Phone: 303-415-4355    Fax: 303-666-1982

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.